SPONSOR
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Total Trials
8
Recruiting
8
Phases
Phase 2
Conditions studied: Endocrine DiseasesKidney DiseaseNephrotic SyndromeAlcohol Use DisorderLipodystrophyChronic Hepatitis BACTHCushing's SyndromeAcute Liver FailureFulminant Hepatic Failure
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is a clinical research sponsor with 8 registered studies on ClinicalTrials.gov, of which 8 are actively recruiting participants. Research covers conditions including Endocrine Diseases, Kidney Disease, Nephrotic Syndrome, Alcohol Use Disorder.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
How many clinical trials has National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) sponsored?
ClinicalMetric currently tracks 8 clinical trials sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), of which 8 are actively recruiting participants. These trials cover conditions including Endocrine Diseases, Kidney Disease, Nephrotic Syndrome. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) research focus on?
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) clinical trials span Endocrine Diseases, Kidney Disease, Nephrotic Syndrome, Alcohol Use Disorder, Lipodystrophy, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) clinical trial?
To participate in a National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) trials with current recruitment status updated daily.
Clinical Trials by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT02830308
Recruiting
Evaluation of Adults With Endocrine and Metabolic-Related Conditions
Endocrine Diseases
NCT00001979
Recruiting
Immune System Related Kidney Disease
Kidney Disease
NCT07191561
Recruiting
Hepatic Lipid Metabolism-Alcohol Use Disorder
Alcohol Use Disorder
NCT05996536
Recruiting
Feasibility of Adipose Tissue Triglyceride (TG) Labelling in Familial Partial Lipodystrophy (FPLD)
Lipodystrophy
NCT06092333 Phase 2
Recruiting
VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B
Chronic Hepatitis B
NCT02019706 Phase 2
Recruiting
Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome
ACTH
NCT04862221 Phase 2
Recruiting
TReatment for ImmUne Mediated PathopHysiology
Acute Liver Failure
NCT04685200
Recruiting
Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach
Primary Sclerosing Cholangitis
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology